...
【24h】

A review of chitosan and its derivatives in bone tissue engineering

机译:壳聚糖及其衍生物在骨组织工程中的研究进展

获取原文
获取原文并翻译 | 示例

摘要

Critical-sized bone defects treated with biomaterials offer an efficient alternative to traditional methods involving surgical reconstruction, allografts, and metal implants. Chitosan, a natural biopolymer is widely studied for bone regeneration applications owing to its tunable chemical and biological properties. However, the potential of chitosan to repair bone defects is limited due to its water insolubility, faster in vivo depolymerization, hemo-incompatibility, and weak antimicrobial property. Functionalization of chitosan structure through various chemical modifications provides a solution to these limitations. In this review, current trends of using chitosan as a composite with other polymers and ceramics, and its modifications such as quaternization, carboxyalkylation, hydroxylation, phosphorylation, sulfation and copolymerization in bone tissue engineering are elaborated. (C) 2016 Elsevier Ltd. All rights reserved.
机译:用生物材料处理的临界大小的骨缺损可以有效替代传统方法,包括外科手术重建,同种异体移植和金属植入物。壳聚糖是一种天然生物聚合物,由于其可调节的化学和生物学特性而被广泛研究用于骨再生。然而,壳聚糖修复骨骼缺陷的潜力由于其水不溶性,体内更快的解聚速度,血液不相容性和弱的抗菌性而受到限制。通过各种化学修饰使壳聚糖结构功能化可解决这些局限性。在这篇综述中,阐述了在骨组织工程中使用壳聚糖与其他聚合物和陶瓷作为复合材料的当前趋势及其修饰,例如季铵化,羧烷基化,羟基化,磷酸化,硫酸化和共聚。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号